UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2017, Eighth edition., ISBN 9780702061851, xvii, 1143 pages
Book
Current Alzheimer research, ISSN 1567-2050, 12/2007, Volume 4, Issue 5, pp. 501 - 502
Journal Article
2010, 7th ed., ISBN 9781416062318, xxviii, 1119
Book
4.
Full Text
A call for transparent reporting to optimize the predictive value of preclinical research
Nature (London), ISSN 0028-0836, 10/2012, Volume 490, Issue 7419, pp. 187 - 191
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Publishing - trends | Sample Size | Animals | Publishing - standards | Research Design - standards | Statistics as Topic | Random Allocation | Animal experimentation | Medicine, Experimental | Medical research | Research validity | Experimental studies | Standards | Studies | Stroke | Biomedical research | Publications | Journals | Clinical trials | Life sciences | Experiments | Community | Index Medicus
Journal Article
Nature reviews. Neurology, ISSN 1759-4758, 01/2021
Journal Article
Current Alzheimer research, ISSN 1567-2050, 04/2005, Volume 2, Issue 2, pp. 105 - 107
Journal Article
Neurology, ISSN 0028-3878, 01/2019, Volume 92, Issue 2, pp. 84 - 93
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Animals | Humans | Alzheimer Disease - therapy | Translational Medical Research - methods | Disease Progression | Aging - pathology | Alzheimer Disease - pathology | Index Medicus | Abridged Index Medicus | 25 | 36 | 26 | Views & Reviews | 39
Journal Article
2003, 6th ed., ISBN 0443070873, xvii, 1568
Book
9.
Full Text
Accelerating Alzheimer's disease drug innovations from the research pipeline to patients
Alzheimer's & dementia, ISSN 1552-5260, 06/2018, Volume 14, Issue 6, pp. 833 - 836
innovation | drug development | dementia | Alzheimer's disease | pricing | drug pipeline | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Drugs | Medical policy | Medical research | Innovations | College teachers | Homeopathy | Materia medica and therapeutics | Prevention | Pharmacy | Therapeutics | Pricing | Medicine, Experimental | Health care industry | Drug discovery | Drug therapy | Pharmaceutical industry
Journal Article
CNS drugs, ISSN 1172-7047, 06/2017, Volume 31, Issue 6, pp. 495 - 509
Taurine - analogs & derivatives | Alzheimer Disease - physiopathology | Genetic Predisposition to Disease | Peptide Fragments - metabolism | Apolipoprotein E4 - genetics | Prodrugs | Magnetic Resonance Spectroscopy | Humans | Alzheimer Disease - drug therapy | Models, Molecular | Molecular Dynamics Simulation | Dose-Response Relationship, Drug | Mass Spectrometry | Amyloid beta-Peptides - metabolism | Drug Design | Ion Mobility Spectrometry - methods | Taurine - administration & dosage | Taurine - pharmacology | Alzheimer Disease - genetics | Taurine - pharmacokinetics | Brain | Stoichiometry | Nuclear magnetic resonance--NMR | Peptides | Toxicity | Central nervous system | Cognitive ability | Clinical trials | Amino acids | Nervous system | Drug development | Monomers | Magnetic resonance spectroscopy | Neurotoxicity | Developmental stages | Protein folding | Alzheimer's disease | Apolipoprotein E4 | Spectroscopy | Translation | Pharmacodynamics | Neurodegenerative diseases | Data processing | Mass spectroscopy | Apolipoproteins | Homozygotes | Studies | β-Amyloid | Scientific imaging | Alzheimers disease | Mass spectrometry | Conformation | Index Medicus
Journal Article
BMC neurology, ISSN 1471-2377, 02/2019, Volume 19, Issue 1, pp. 33 - 33
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Prevalence | Dementia - psychology | Comorbidity | United States | Humans | Middle Aged | Cost of Illness | Male | Dementia - economics | Health Care Costs | Patient Acceptance of Health Care | Problem Behavior | Female | Aged | Retrospective Studies | Databases, Factual | Utilization | Antipsychotic drugs | Nursing | Databases | Antidepressants | Medical care | Alzheimer's disease | Medical care, Cost of | Caregivers | Agitation | Resource utilization | Neuroleptics | Medicare | Health care policy | Data processing | Patients | Psychotropic drugs | Psychosis | Prescription drugs | Hospitals | Health care expenditures | Polypharmacy | Older people | Dementia disorders | Behavior | Alzheimers disease | Dementia | Index Medicus | Healthcare resource utilization | Neuropsychological symptoms | Behavioral disturbances | Alzheimer’s disease
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 01/2014, Volume 10, Issue 1, pp. 109 - 114
Neurology | Early diagnosis | Biomarker | Diagnostics | Alzheimer's disease | Blood based biomarker | Early detection | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Biomarkers - blood | Enzyme-Linked Immunosorbent Assay | Early Diagnosis | Humans | Disease Progression | Alzheimer Disease - blood | Development and progression | Neurosciences | Biological markers | Public health | Amyloid beta-protein | Index Medicus
Journal Article
Alzheimer's & dementia, ISSN 1552-5260, 01/2020, Volume 16, Issue 1, pp. 131 - 143
Biomarker | GRN | FTLD | Frontotemporal lobar degeneration | Primary progressive aphasia | ARTFL | Progressive supranuclear palsy | FTD | Clinical trial | LEFFTDS | MAPT | Frontotemporal dementia | C9orf72 | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Index Medicus
Journal Article